{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-7813", "postId": 7813, "name": "Ardent Health, Inc.", "description": "Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. (\u201cArdent\u201d or the \u201cCompany\u201d) (NYSE: ARDT) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose information regarding Ardent Health’s accounts receivable. During the Class Period, Defendants publicly reported the Company\u2019s accounts receivable on a quarterly basis.\u00a0In addition, Defendants represented that the Company maintained professional malpractice liability insurance in amounts \u201csufficient to cover claims arising out of its operations.\u201d Lead Plaintiff Deadline: March 9, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "ARDT", "legal": { "court": "", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "07/18/2024", "end": "11/12/2025" }, "leadPlaintiffDeadline": "03/09/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/ardent-health-inc/", "canonicalUrl": "https://faruqilaw.com/case/ardent-health-inc/", "datePublished": "2026-01-08T20:57:05+00:00", "dateModified": "2026-01-15T18:28:06+00:00", "associatedOrganization": { "@id": "case-7813-org" }, "legalService": { "@id": "case-7813-legalservice" }, "hasPart": [ { "@id": "case-7813-faq" }, { "@id": "case-7813-press-list" } ], "legalRepresentation": [ { "@id": "case-7813-attorney-516" }, { "@id": "case-7813-attorney-506" } ] }, { "@type": "Organization", "@id": "case-7813-org", "name": "Ardent Health, Inc.", "identifier": "ARDT", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://ardenthealth.com/" }, { "@type": "LegalService", "@id": "case-7813-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-7813-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-7813-legalservice" } }, { "@type": "Person", "@id": "case-7813-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-7813-legalservice" } }, { "@type": "FAQPage", "@id": "case-7813-faq", "mainEntity": [ { "@type": "Question", "name": "What are the main allegations in the Ardent Health (ARDT) securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit alleges Ardent Health and its executives violated federal laws by making false or misleading statements regarding the company\u2019s accounts receivable. It also claims the company misrepresented that its professional malpractice insurance was sufficient to cover all operational claims." } }, { "@type": "Question", "name": "Who is eligible to participate in the Ardent Health investor class action?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased Ardent Health (NYSE: ARDT) securities during the specified Class Period and suffered financial losses may be eligible. Participants must review their trade dates against the period defined in the complaint to determine if their losses qualify for potential recovery." } }, { "@type": "Question", "name": "What is the deadline to join the Ardent Health (ARDT) lawsuit as a lead plaintiff?", "acceptedAnswer": { "@type": "Answer", "text": "The deadline for investors to move the court to serve as lead plaintiff in the Ardent Health securities litigation is March 9, 2026. This role allows an investor to oversee the legal proceedings on behalf of the entire class, though you can still remain a class member without being a lead." } }, { "@type": "Question", "name": "Why is Faruqi & Faruqi investigating Ardent Health for potential securities fraud?", "acceptedAnswer": { "@type": "Answer", "text": "Faruqi & Faruqi is investigating whether Ardent Health failed to disclose critical information about its accounts receivable and liability coverage. The firm is examining if these alleged omissions artificially inflated the stock price, leading to investor losses when the truth emerged." } }, { "@type": "Question", "name": "How does the Ardent Health lawsuit describe the company's malpractice insurance issues?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint alleges Ardent Health falsely represented its professional malpractice liability insurance as being in amounts sufficient to cover claims arising from operations. The investigation seeks to prove these statements were misleading or lacked a reasonable basis at the time they were made." } } ] }, { "@type": "NewsArticle", "@id": "case-7813-press-1", "headline": "SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health", "url": "https://www.newsfilecorp.com/release/280384/SHAREHOLDER-ALERT-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-Ardent-Health", "datePublished": "2026-01-15" }, { "@type": "NewsArticle", "@id": "case-7813-press-2", "headline": "Earnings call transcript: Ardent Health Q3 2025 reports revenue growth, stock plunges", "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-ardent-health-q3-2025-reports-revenue-growth-stock-plunges-93CH-4356017", "datePublished": "2025-11-13" }, { "@type": "ItemList", "@id": "case-7813-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-7813-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-7813-press-2" } } ] } ] }

Ardent Health, Inc.

Ardent Health, Inc.

Join Action
Case Details
Ticker ARDT
Class Period 07/18/2024 - 11/12/2025
Lead Plaintiff Deadline 03/09/2026
Days Left to Seek Plaintiff
35

If you are an Ardent Health investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose information regarding Ardent Health’s accounts receivable. During the Class Period, Defendants publicly reported the Company’s accounts receivable on a quarterly basis. In addition, Defendants represented that the Company maintained professional malpractice liability insurance in amounts “sufficient to cover claims arising out of its operations.”

📞 Lead Plaintiff Deadline: March 9, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
Ardent Health, Inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771